Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Theranostic nanoparticles for tracking and monitoring disease state

13.11.2017

Although the most basic definition of a "theranostic" nanoparticle is a nanoparticle that simply has a therapeutic moiety and imaging or diagnostic moiety on the same particle, the authors of a new SLAS Technology review article pay particular attention to and emphasize the platforms in which self-reporting and disease monitoring is possible in real-time through the synergistic nature of the components on the theranostic particles.

The review is organized into theranostic nanoparticles of specific imaging and diagnostic modalities, including optical imaging, magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and nuclear imaging.


This is from the SLAS Technology article "Theranostic Nanoparticles for Tracking and Monitoring Disease State."

Image by Peter Allen

The evolving nature of the field toward such responsive and "smart" theranostic nanoparticles can be used as tools for life sciences researchers, especially in the context of identifying markers and characterizing cells and diseases over the course of its lifetime.

Many clinical imaging technologies have limitations in resolution when detecting small quantities of molecular markers, but theranostic nanoparticles can be used in combination to provide early detection and therapy of diseases, and has the potential to advance imaging platforms for improved performance.

###

Visit SLAS Technology Online at journals.sagepub.com/doi/full/10.1177/2472630317738698 to read Theranostic Nanoparticles for Tracking and Monitoring Disease State for free for a limited time. SLAS Technology is one of two PubMed:MEDLINE-indexed scientific journals published by SLAS. For more information about SLAS and its journals, visit http://www.slas.org/ journals.

The article Theranostic Nanoparticles for Tracking and Monitoring Disease State will be available at journals.sagepub.com/doi/full/10.1177/2472630317738698 on Nov. 9. In the meantime, credentialed media representatives may contact Nan Hallock for a PDF.

Media Contact

Nan Hallock
nhallock@slas.org
630-256-7527 x106

 @SLAS_Org

https://www.slas.org/ 

Nan Hallock | EurekAlert!

More articles from Medical Engineering:

nachricht 2 million euros in funding for new MR-compatible electrophysiological brain implants
18.12.2017 | Max-Planck-Institut für biologische Kybernetik

nachricht PET identifies which prostate cancer patients can benefit from salvage radiation treatment
05.12.2017 | Society of Nuclear Medicine and Molecular Imaging

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

Im Focus: Autoimmune Reaction Successfully Halted in Early Stage Islet Autoimmunity

Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.

Type 1 diabetes is the most common metabolic disease in childhood and adolescence. In this disease, the body's own immune system attacks and destroys the...

Im Focus: Leaving Flatland – Quantum Hall Physics in 4D

Researchers from LMU/MPQ implement a dynamical version of the 4D quantum Hall effect with ultracold atoms in an optical superlattice potential

In literature, the potential existence of extra dimensions was discussed in Edwin Abbott’s satirical novel “Flatland: A Romance of Many Dimensions” (1884),...

Im Focus: Tweaking quantum dots powers-up double-pane solar windows

Engineered quantum dots could bring down the cost of solar electricity

Using two types of "designer" quantum dots, researchers are creating double-pane solar windows that generate electricity with greater efficiency and create...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Engineers make wearable sensors for plants, enabling measurements of water use in crops

08.01.2018 | Information Technology

In scientific first, IU researchers grow hairy skin in a dish

08.01.2018 | Health and Medicine

Research paves the way for treatment strategies of multidrug-resistant chronic infections

08.01.2018 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>